AEVIS Holding SA: Strong increase of the net half-yearly result – 2013 objectives confirmed

AEVIS Holding SA  / Key word(s): Final Results

30.09.2013 07:25

Release of an ad hoc announcement pursuant to Art. 53 KR

Turnover up 34% to CHF 216.8 million (CHF 161.8m) - EBITDA surged by 60.8%
to CHF 24.7 million (CHF 15.4m) - Net profit of CHF 4.9 million (CHF 0.9m)

AEVIS Holding SA (AEVIS) today published its half-year report 2013. The
company has made further progress in the implementation of its expansion
strategy during the first semester and realised strongly increasing
results. Total revenues amounted to CHF 216.8 million, an increase of 34.0%
compared to the same period last year (CHF 161.8 million). Excluding the
effects of the newly acquired clinics, organic growth amounted to 7.4%.
EBITDA surged significantly to CHF 24.7 million or 60.8% more than in the
previous year (CHF 15.4 million). The strong growth in operating profit was
generated by efficiency gains at Genolier Swiss Medical Network (GSMN) and
the consolidation of Swiss Healthcare Properties (SHP, part of AEVIS since
1 July 2012). The profit for the period under review amounted to CHF 4.9
million (CHF 0.9m) or CHF 0.33 per share.

GSMN continues to expand
AEVIS' main subsidiary, Genolier Swiss Medical Network (GSMN), continued
its acquisition strategy with the purchase of Hôpital de la Providence in
Neuchatel (Canton Neuchatel) and Clinique de Valère in Sion (Canton
Valais). A turnover growth of 30.9% to CHF 183.3 million (CHF 139.9m)
resulted in the reporting period. Since the beginning of the second
half-year 2013, Klinik Villa im Park in Rothrist (Canton Aargau) and
Schmerzklinik Basel (Canton Basel-Stadt) have been added to the network.
GSMN is the only Swiss group of private clinics present in all three
linguistic regions, combining 14 clinics in ten cantons as well as one
affiliated clinic (Pyramide am See). Regulatory changes will accentuate the
consolidation movement in the sector and GSMN, with its decentralised and
federal structure, reinforces its attractiveness for private independent
clinics wishing to integrate a national network.

SHP portfolio strengthened in 2013
Since the beginning of 2013, SHP enlarged its focused medical real estate
portfolio to 25 entities located on ten specific sites. The integration of
the buildings of Clinique de Valère in Sion and of the site of Privatklinik
Bethanien in Zurich have been finalised. All properties, which are mostly
rented by GSMN, are fully let and today represented a market value of
approx. CHF 605.6 million. SHP plans to pursue the development of its
portfolio and examines several acquisition projects of clinics,
clinic-related buildings or hotels. The company also studies several
Public-Private Partnerships linked to the implementation of the new
hospital financing system.
Outlook 2013
In the remainder of 2013, AEVIS will focus on the integration and
restructuring of its new entities as well as on generally improving the
group's efficiency. Based on both internal growth and new acquisitions
already realised since the beginning of the current year, AEVIS expects to
reach revenues of more than CHF 450 million in the fiscal year 2013. With
the new acquisitions fully consolidated, the 2014 turnover will exceed CHF
500 million. In the mid-term, AEVIS plans to realise an EBITDA of more than
20% based on the optimisation of its existing facilities and the
diversification of its activities, in line with the industry benchmark.
AEVIS plans to reinforce its distribution policy to shareholders in 2013.
The company moreover successfully issued a bond of CHF 100 million,
allowing it to diversify its financing sources and to increase its
investment capacity.

New developments and investments
AEVIS pursues the enlargement of its scope of activity with participating
interests and investments in healthcare, life sciences, services to people
or lifestyle. With its better-aging brand « Nescens », AEVIS has
established a transversal relation linking cosmeceutical (Laboratoires
Genolier CSPV SA), medical (check-up centres of the clinics), aesthetic
(Clinique Nescens - Paris Spontini) and hotel related activities (SPAs - La
Réserve Hotels).  In the future, AEVIS plans to particularly develop those
activities which are not part of the regulated health system.

Detailed reporting
The full Half-Year Report 2013 of AEVIS Holding SA can be downloaded via
this link:

For further information:
AEVIS Holding AG Media and Investor Relations: c/o Dynamics Group, Zurich
Edwin van der Geest,, 
+41 (0) 43 268 32 35 or +41 (0) 79 330 55 22
Philippe R. Blangey,, 
+41 (0) 43 268 32 35 or +41 (0) 79 785 46 32

About AEVIS Holding 
AEVIS Holding SA invests in the healthcare sector, life sciences, services
to people and lifestyle. AEVIS's main shareholdings are Genolier Swiss
Medical Network, the second largest group of private clinics in
Switzerland, Swiss Healthcare Properties AG, a company specialised in
medical real estate, Nescens SA, a brand dedicated to better aging, and AS
Ambulances Services SA. AEVIS employs nearly 3'000 persons and collaborates
with 1'300 independent physicians. AEVIS wishes to progressively develop
new sectors of activity, amongst others in the sector of outpatient
surgical centres, radiology and dental medicine and hotel or hotel-related
activities. AEVIS Holding SA is listed on the Domestic Standard segment of
the SIX Swiss Exchange under the ticker AEVS.SW.

30.09.2013 News transmitted by EQS Schweiz AG. 
The issuer is responsible for the contents of the release.

EquityStory publishes regulatory releases, media releases on the capital 
market and press releases.
The EquityStory Group distributes authentic and real-time financial news 
for over 1'300 listed companies. 
The Swiss news archive can be found at